How much does ibrutinib/ibrutinib typically cost per year?

Ibrutinib is a targeted drug that is widely used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrom's macroglobulinemia (WM), and chronic graft-versus-host disease (cGVHD). As a targeted therapy, ibrutinib has played an important role in improving survival rates and quality of life in patients with these diseases. However, the cost of ibrutinib use is one of the important factors that patients must consider when receiving treatment.

The standard dose of ibrutinib is usually 420 mg once daily. Patients need to take their medications on time to ensure treatment is effective, and periodic discontinuation of medication is usually not required unless severe side effects occur or disease progression occurs. While taking ibrutinib, patients need to be monitored regularly to ensure the safety and efficacy of the drug.

Taking the domestic market as an example, the original drug of ibrutinib is usually 140 mg in size. Each bottle contains 90 capsules and sells for about 10,000 yuan. If the patient takes the recommended dose once a day, the annual drug cost will be about 120,000 yuan based on 365 days a year. This is the cost of using original drugs, while generic drugs are relatively cheaper, especially in countries with lower production costs of generic drugs, such as Bangladesh and India. Patients can choose generic drugs to reduce their financial burden.

For example, each bottle of generic ibrutinib produced by some pharmaceutical companies in Bangladesh140 mg*112 capsules is priced at more than 2,000 yuan, and the annual cost is relatively low. If patients choose generic drugs for treatment, the cost of treatment may be greatly reduced, especially for patients with difficult economic conditions, generic drugs are an important choice.

Reference materials:https://www.imbruvica.com/